Literature DB >> 17492446

SPECT-CT: a valuable method to document the regeneration of lymphatics and autotransplanted lymph node fragments.

K S Blum1, C Radtke, W H Knapp, R Pabst, K F Gratz.   

Abstract

PURPOSE: The transplantation of lymph node fragments and stimulation of lymph vessel regeneration seems to be a promising model to prevent lymphoedema in patients after mammary tumour excision combined with axillary lymph node dissection and irradiation. This study evaluated the advantages of SPECT-CT in studying the regeneration of lymph vessels and lymphoid tissue after autologous lymph node transplantation.
METHODS: Five minipigs underwent autologous lymph node transplantation in the left groin. The lymph node was excised, cut into six pieces and embedded into two newly created subcutaneous pouches on this side. The superficial lymph node of the right groin was removed as a control. Five months after surgery the lymph flow of both legs was investigated using conventional lymphoscintigraphy and SPECT-CT with 10 MBq(99m)Tc-nanocolloid in combination with Berlin Blue injected subcutaneously into the draining area.
RESULTS: The integration of the transplanted lymph node fragments was shown. The SPECT-CT results correlated with the in situ findings observed at dissection. Afferent and efferent lymph flow could be followed up to the lumbar trunks. The use of SPECT-CT allowed exact localisation of the lymph node fragments in three-dimensional space and the regeneration of the lymph node fragments was documented histologically.
CONCLUSION: SPECT-CT is a good method to evaluate lymphatic flow and document lymph node regeneration. The data suggest that autologous lymph node transplantation is a promising model for prevention of lymphoedema.

Entities:  

Mesh:

Year:  2007        PMID: 17492446     DOI: 10.1007/s00259-007-0458-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  27 in total

1.  Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection.

Authors:  P Schrenk; M Hatzl-Griesenhofer; A Shamiyeh; W Waynad
Journal:  J Surg Oncol       Date:  2001-07       Impact factor: 3.454

2.  SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma.

Authors:  Arne Wagner; Kurt Schicho; Christoph Glaser; Georg Zettinig; Kaan Yerit; Susanne Lang; Clemens Klug; Thomas Leitha
Journal:  J Craniomaxillofac Surg       Date:  2004-12       Impact factor: 2.078

3.  Use of lymphoscintigraphy with SPECT/CT for sentinel node localization in a case of vaginal melanoma.

Authors:  Walter Kim; Yusuf Menda; Jason Willis; Twyla B Bartel; Michael M Graham
Journal:  Clin Nucl Med       Date:  2006-04       Impact factor: 7.794

4.  Long-term morbidity following axillary dissection in breast cancer patients--clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors.

Authors:  T Kuehn; W Klauss; M Darsow; S Regele; F Flock; C Maiterth; R Dahlbender; I Wendt; R Kreienberg
Journal:  Breast Cancer Res Treat       Date:  2000-12       Impact factor: 4.872

5.  Regeneration of autotransplanted lymph node fragments.

Authors:  R Pabst; H J Rothkötter
Journal:  Cell Tissue Res       Date:  1988-03       Impact factor: 5.249

6.  Evaluation of transport kinetics in lymphoscintigraphy: follow-up study in patients with transplanted lymphatic vessels.

Authors:  E Kleinhans; R G Baumeister; D Hahn; S Siuda; U Büll; E Moser
Journal:  Eur J Nucl Med       Date:  1985

7.  Dynamic lymph flow imaging in patients with oedema of the lower limb for evaluation of the functional outcome after autologous lymph vessel transplantation: an 8-year follow-up study.

Authors:  Mayo Weiss; Rüdiger G H Baumeister; Klaus Hahn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-11-29       Impact factor: 9.236

Review 8.  The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema.

Authors:  Andrzej Szuba; William S Shin; H William Strauss; Stanley Rockson
Journal:  J Nucl Med       Date:  2003-01       Impact factor: 10.057

9.  Lymphatic drainage patterns from the breast.

Authors:  Susanne H Estourgie; Omgo E Nieweg; Renato A Valdés Olmos; Emiel J Th Rutgers; Bin B R Kroon
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

10.  Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy.

Authors:  D Larson; M Weinstein; I Goldberg; B Silver; A Recht; B Cady; W Silen; J R Harris
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-09       Impact factor: 7.038

View more
  6 in total

Review 1.  Lymph node dissection--understanding the immunological function of lymph nodes.

Authors:  M Buettner; U Bode
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

Review 2.  The Lymphatic System in Disease Processes and Cancer Progression.

Authors:  Timothy P Padera; Eelco F J Meijer; Lance L Munn
Journal:  Annu Rev Biomed Eng       Date:  2016-02-05       Impact factor: 9.590

3.  Lymph node transplantation and its immunological significance in animal models.

Authors:  Manuela Buettner; Ulrike Bode
Journal:  Clin Dev Immunol       Date:  2011-05-25

4.  Estimating Lymphodynamic Conditions and Lymphovenous Anastomosis Efficacy Using (99m)Tc-phytate Lymphoscintigraphy with SPECT-CT in Patients with Lower-limb Lymphedema.

Authors:  Takeshi Iimura; Yoshimitsu Fukushima; Shinichiro Kumita; Rei Ogawa; Hiko Hyakusoku
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-06-05

Review 5.  The pig as a model for immunology research.

Authors:  Reinhard Pabst
Journal:  Cell Tissue Res       Date:  2020-04-30       Impact factor: 5.249

Review 6.  Current Advancements in Animal Models of Postsurgical Lymphedema: A Systematic Review.

Authors:  Jerry F Hsu; Roy P Yu; Eloise W Stanton; Jin Wang; Alex K Wong
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-08-27       Impact factor: 4.947

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.